Skip to main content

Table 1 Demographic and clinical characteristics, postoperative treatment, and outcome at baseline of participants in this study

From: Myxoid stroma is associated with postoperative relapse in patients with stage II colon cancer

Characteristics

Number (%)

Characteristics

Number (%)

Gender

 

Surgical margin

 

 Male

94 (55.6)

 Negative

163 (96.4)

 Female

75 (44.4)

 Positive

6 (3.6)

Age (yr, average, range)

70.5 (29–92)

Glucose tolerance

 

Preoperative serum CEA value

 

 Normal

120 (71.0)

  < 5

106 (62.7)

 Abnormal

49 (29.0)

  ≥ 5

63 (37.3)

Obstruction / perforation

 

Preoperative serum CA19–9 value

 

 Absence

157 (92.9)

  < 37

143 (84.6)

 Presence

12 (7.1)

  ≥ 37

26 (15.4)

Surgical approach

 

Tumor location

 

 Laparotomy

101 (59.8)

 Right

88 (52.1)

 Laparoscopic surgery

68 (40.2)

 Left

81 (47.9)

Examined lymph node

 

Tumor size (cm, average, range)

5.0 (1–17)

  ≥ 12

115 (68.0)

Differentiation

 

  < 12

54 (32.0)

 Well, Mod, pap

150 (88.8)

Postoperative adjuvant chemotherapy

 

 Por, Muc, Sig

19 (11.2)

 No

147 (86.1)

pT category

 

 Yes

22 (13.9)

 pT3

144 (85.2)

Postoperative relapse

n = 23

 pT4a

13 (7.7)

 Lung

6

 pT4b

12 (7.1)

 Liver

8

Lymphatic invasion

 

 Peritoneum

5

 Absent

104 (61.5)

 Paraaortic lymph node

3

 Present

65 (38.5)

 Local relapse

1

Vessel invasion

 

Desmoplastic reaction

 

 Absent

71 (42.0)

 Mature stroma

76 (45.0)

 Present

98 (58.0)

 Intermediate stroma

62 (36.1)

Tumor budding

 

 Myxoid (i.e. immature) stroma

32 (18.9)

 Grade 1

106 (62.7)

  

 Grade 2

43 (25.4)

  

 Grade 3

20 (11.9)

 Â